Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
i just wasted 10 minutes of my life reading the ****e on that board. on the basis i can read ****e many times faster than it takes people to write it i just have to ask myself why they bother. it reads like a football supporters board.
He's not throwing money away. At least I hope he isn't!!!
All Director deals are published. Not sure how soon after though. I think Cathal's buy is not really that significant whenever it happens. He already owns 46,000,000 shares so another one or two is hardly going to make any difference. He is trying to show confidence in ORPH but the proof is in the business not in whether a Director who already has nearly 7% of the company buys a little more.
10 June 2021: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, announces the following update from Dr Miroslav Reljanovic, Executive Chairman, in advance of the Company's closed Annual General Meeting ('AGM') to be held this morning at 9.30am:
"Ergomed has had a strong start to 2021. In the year to date, the conclusion of our strategic transition to a services-based business model, coupled with our ongoing resilience globally through the COVID-19 pandemic, has enabled the Company to build further on the momentum seen in 2020.
"The Company has continued to make significant strategic progress in the current year. With the integration of the Ashfield Pharmacovigilance business successfully concluded, PrimeVigilance, the Company's pharmacovigilance division, has seen continued strong growth in revenues in line with prior trends. In the CRO business, integration of MedSource, which was acquired in December 2020, is progressing well and our CRO business as a whole is seeing further acceleration in the growth that resumed in the second half of 2020.
"Alongside strong organic growth, the integration of the two new businesses is continuing to fuel rapid development of the Company's operational presence in the US. At the same time, the Company's international growth is continuing, with ongoing expansion into further geographic areas, including the recently announced new operation in Japan, the fourth largest pharmaceutical market in the world.
"With continuing strong sales and order book growth, solid trading in the first months of the year, effective cost management and acquisition synergies, the Board currently expects adjusted EBITDA for the full year to be materially ahead of market expectations. Reported revenues for the full year are expected to be in line with market expectations, notwithstanding a higher proportion of US dollar denominated revenues leading to some FX headwinds.
"In accordance with our usual practice, in July 2021 we will provide a more detailed report on current trading and a further update on the outlook for the 2021 financial year as a whole.
"Finally, on behalf of the Board, I would like to thank all of the Company's colleagues and shareholders for their continuing support through the challenging times of the past year, as we look forward with optimism to the rest of the year."
According to previous poster here because presentation is after market close an RNS could come tomorrow morning 7am so everything in the presentation is in the public domain before the market opens tomorrow.
Surely CF must be presenting some news later otherwise what is the point in just repeating what we already know? Doesn't that make an RNS tomorrow more likely than not?
It's in among a few others at the same price and they are all showing as sells.
My guess would be that he will use the same day to post a trading update for 2021.
Not for a while yet according to Stockopedia
Monday, June 21st 2021
Full Year 2020 Open Orphan PLC Earnings Release
My buy is showing as a sell just as I thought.
I've just bought at £4.678 so a few of those trades showing as sells could be buys. My W-8BEN came through this morning. Shame it wasn't 24 hours earlier! Think this one is a good LTBH.
I've got the telegram app but cant find the ORPH group. What should I be searching on to find it? Or am I just being dim?
Full details are outlined in the Circular, which will be posted to Shareholders today and will shortly be available, in accordance with AIM Rule 20, here:
https://www.openorphan.com/investors/circulars-and-admission-document
When will the 2020 results be published? I can't find any reference to a date, not even on ORPH website. I assume a loss is expected?